Panel: No silver bullet for drug prices
As drug prices increase, states can pursue a number of policy maneuvers to help bend the cost curve, experts said at an Evidence-Based Health Policy Project briefing in Madison last week.
To access this content, you must purchase a Premium membership, or log in if you are a member.
